{"title":"新诊断的2型糖尿病患者血清和唾液抵抗素水平的评估。","authors":"Dasari Ramya, Vandana Raghunath, Polisetty Siva Krishna, Firoz Kamal, H Aparna Latha","doi":"10.4103/jomfp.jomfp_219_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes mellitus represents a significant health concern, projected to impact 449 million individuals worldwide by the year 2030. The factors linking obesity and insulin resistance (IR) have been an emerging topic of research, owing to the novel group of factors discovered, the \"adipocytokines\". One such inflammatory adipocytokine is Resistin, which has been crucial to the development of (IR), which subsequently leads to type II diabetes mellitus (T2DM), due to its significant pro inflammatory properties. However, serological studies present conflicting evidence on resistin's link to obesity, IR, and T2DM and only one salivary study exists, with none in the Indian population. With saliva harboring many biomarkers, there lies a probability of resistin being labelled as one. It could facilitate earlyT2DM diagnosis and be monitored to prevent or delay complications. Thus, to unravel the enigmatic role of Resistin in T2DM, this study was undertaken.</p><p><strong>Materials and methods: </strong>Participants in the study were categorized into 2 groups, Group-I (T2DM), consisting of 30 newly diagnosed T2DM and Group- II (HC) with 30 healthy non-Diabetic participants. Serum and salivary resistin levels were measured using the Enzyme-linked Immunosorbent assay. Fasting blood sugar (FBS), HbA1C, and the inflammatory marker hs-CRP were assessed using Trinder's GOD/POD estimation, chromatographic and Turbidimetric Immuno assays respectively.</p><p><strong>Results: </strong>Higher mean values of serum resistin & salivary resistin were observed in Group I (T2DM) (10.5730 + 11.11936) & (10.2643 + 13.77515) compared to Group II (HC) individuals (6.4787 + 6.44202) & (3.7577 + 4.62597) respectively. It was statistically significant with a p value of 0.38 & 0.32 respectively.</p><p><strong>Conclusion: </strong>However, no correlation could be established between the diabetic markers FBS, HbA1C, hs-CRP and serum or salivary resistin. A negative correlation (-0.208) was observed between serum & salivary resistin.</p>","PeriodicalId":38846,"journal":{"name":"Journal of Oral and Maxillofacial Pathology","volume":"29 2","pages":"254-259"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12283052/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessment of serum and salivary resistin levels in newly diagnosed type-II diabetes mellitus patients.\",\"authors\":\"Dasari Ramya, Vandana Raghunath, Polisetty Siva Krishna, Firoz Kamal, H Aparna Latha\",\"doi\":\"10.4103/jomfp.jomfp_219_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Diabetes mellitus represents a significant health concern, projected to impact 449 million individuals worldwide by the year 2030. The factors linking obesity and insulin resistance (IR) have been an emerging topic of research, owing to the novel group of factors discovered, the \\\"adipocytokines\\\". One such inflammatory adipocytokine is Resistin, which has been crucial to the development of (IR), which subsequently leads to type II diabetes mellitus (T2DM), due to its significant pro inflammatory properties. However, serological studies present conflicting evidence on resistin's link to obesity, IR, and T2DM and only one salivary study exists, with none in the Indian population. With saliva harboring many biomarkers, there lies a probability of resistin being labelled as one. It could facilitate earlyT2DM diagnosis and be monitored to prevent or delay complications. Thus, to unravel the enigmatic role of Resistin in T2DM, this study was undertaken.</p><p><strong>Materials and methods: </strong>Participants in the study were categorized into 2 groups, Group-I (T2DM), consisting of 30 newly diagnosed T2DM and Group- II (HC) with 30 healthy non-Diabetic participants. Serum and salivary resistin levels were measured using the Enzyme-linked Immunosorbent assay. Fasting blood sugar (FBS), HbA1C, and the inflammatory marker hs-CRP were assessed using Trinder's GOD/POD estimation, chromatographic and Turbidimetric Immuno assays respectively.</p><p><strong>Results: </strong>Higher mean values of serum resistin & salivary resistin were observed in Group I (T2DM) (10.5730 + 11.11936) & (10.2643 + 13.77515) compared to Group II (HC) individuals (6.4787 + 6.44202) & (3.7577 + 4.62597) respectively. It was statistically significant with a p value of 0.38 & 0.32 respectively.</p><p><strong>Conclusion: </strong>However, no correlation could be established between the diabetic markers FBS, HbA1C, hs-CRP and serum or salivary resistin. A negative correlation (-0.208) was observed between serum & salivary resistin.</p>\",\"PeriodicalId\":38846,\"journal\":{\"name\":\"Journal of Oral and Maxillofacial Pathology\",\"volume\":\"29 2\",\"pages\":\"254-259\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12283052/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oral and Maxillofacial Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jomfp.jomfp_219_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral and Maxillofacial Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jomfp.jomfp_219_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Assessment of serum and salivary resistin levels in newly diagnosed type-II diabetes mellitus patients.
Introduction: Diabetes mellitus represents a significant health concern, projected to impact 449 million individuals worldwide by the year 2030. The factors linking obesity and insulin resistance (IR) have been an emerging topic of research, owing to the novel group of factors discovered, the "adipocytokines". One such inflammatory adipocytokine is Resistin, which has been crucial to the development of (IR), which subsequently leads to type II diabetes mellitus (T2DM), due to its significant pro inflammatory properties. However, serological studies present conflicting evidence on resistin's link to obesity, IR, and T2DM and only one salivary study exists, with none in the Indian population. With saliva harboring many biomarkers, there lies a probability of resistin being labelled as one. It could facilitate earlyT2DM diagnosis and be monitored to prevent or delay complications. Thus, to unravel the enigmatic role of Resistin in T2DM, this study was undertaken.
Materials and methods: Participants in the study were categorized into 2 groups, Group-I (T2DM), consisting of 30 newly diagnosed T2DM and Group- II (HC) with 30 healthy non-Diabetic participants. Serum and salivary resistin levels were measured using the Enzyme-linked Immunosorbent assay. Fasting blood sugar (FBS), HbA1C, and the inflammatory marker hs-CRP were assessed using Trinder's GOD/POD estimation, chromatographic and Turbidimetric Immuno assays respectively.
Results: Higher mean values of serum resistin & salivary resistin were observed in Group I (T2DM) (10.5730 + 11.11936) & (10.2643 + 13.77515) compared to Group II (HC) individuals (6.4787 + 6.44202) & (3.7577 + 4.62597) respectively. It was statistically significant with a p value of 0.38 & 0.32 respectively.
Conclusion: However, no correlation could be established between the diabetic markers FBS, HbA1C, hs-CRP and serum or salivary resistin. A negative correlation (-0.208) was observed between serum & salivary resistin.
期刊介绍：
The journal of Oral and Maxillofacial Pathology [ISSN:print-(0973-029X, online-1998-393X)] is a tri-annual journal published on behalf of “The Indian Association of Oral and Maxillofacial Pathologists” (IAOMP). The publication of JOMFP was started in the year 1993. The journal publishes papers on a wide spectrum of topics associated with the scope of Oral and Maxillofacial Pathology, also, ensuring scientific merit and quality. It is a comprehensive reading material for the professionals who want to upgrade their diagnostic skills in Oral Diseases; allows exposure to newer topics and methods of research in the Oral-facial Tissues and Pathology. New features allow an open minded thinking and approach to various pathologies. It also encourages authors to showcase quality work done by them and to compile relevant cases which are diagnostically challenging. The Journal takes pride in maintaining the quality of articles and photomicrographs.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
